Data for (Study ST001795)
(Analysis AN002916)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 |
|---|---|---|---|
| 1-18:0-2-18:3-monogalactosyldiacylglycerol | 0.9635 | 0.9514 | 1.0798 |
| 1_2-di-S-octyl-1_2-dimercapto-3-propanol | 1.2999 | 0.6759 | 0.9882 |
| 16-feruloyloxypalmitate | 1.2660 | 0.4871 | 1.1899 |
| 1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5^- diphosphate | 1.0815 | NA | 0.9185 |
| 2-heptaprenyl-3-methyl-6-methoxy-1_4-benzoquinol | 1.1306 | 0.6901 | 1.1449 |
| 3alpha_7alpha_12alpha-Trihydroxy-5beta-cholestan-26-al | 0.1664 | 2.8983 | 0.1463 |
| 3-O-(6^-O-(11Z_14Z_17Z-eicosatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-ol | 1.1356 | 0.8702 | 0.9798 |
| 3-O-(6^-O-(9Z_12Z_15Z-octadecatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-ol | 1.0695 | 0.9536 | 0.9718 |
| 4Z_7Z_10Z_13Z_16Z_19Z_22Z_25Z-octacosaoctaenoic acid | 1.0187 | NA | 0.9876 |
| (4Z_7Z_10Z_13Z_16Z_19Z)-Docosahexaenoic acid ethyl ester | 0.9377 | 1.2142 | 0.8719 |
| 6-Deoxocastasterone | NA | 1.0000 | NA |
| Aeruginopeptin 917S-C | 1.0141 | 0.8514 | 1.1179 |
| Arachidyl palmitoleate | 0.3776 | 1.9053 | 0.6794 |
| Avermectin B2b monosaccharide | 1.1294 | 0.7905 | 1.0568 |
| bafilomycin A1 | 0.5595 | 1.8609 | 0.6752 |
| beta-Tocotrienol | 1.0490 | 0.0374 | 1.7871 |
| Bilirubin | 0.8734 | 1.0306 | 1.0854 |
| CDP-DG(36:2) | 1.0983 | NA | 0.9017 |
| Cer(t18:0/h24:0) | 0.8580 | 1.0994 | 1.0536 |
| CGS 7181 | 0.9804 | 1.1895 | 0.8512 |
| Cholesterolsulfate | 1.0376 | 0.7930 | 1.1464 |
| Citrate | 1.3038 | 0.6145 | 1.0389 |
| Cyanidin 3-(6-acetylgalactoside) | 1.0145 | 0.8518 | 1.1173 |
| Decoside | 0.8956 | NA | 1.0783 |
| Docosahexaenoicacid | 1.0832 | 0.7087 | 1.1757 |
| Docosanoic acid | 1.0951 | 0.6564 | 1.2104 |
| Dodecanoic acid | 1.4256 | 0.0782 | 1.3938 |
| FA (14:1) tetradecenoic acid | 1.1291 | 0.7059 | 1.1324 |
| FA(16:1) | 1.0415 | 1.0249 | 0.9363 |
| FA (16:2) | 0.8232 | 1.4420 | 0.7840 |
| FA (16:3) | 1.1204 | 0.8713 | 0.9939 |
| FA (17:0) | 0.8684 | 1.1968 | 0.9566 |
| FA (18:1) | 1.2448 | 0.5065 | 1.1938 |
| FA (18:2) | 0.6726 | 1.7456 | 0.6647 |
| FA (18:3) | 0.8908 | 1.3043 | 0.8387 |
| FA (18:4) | 1.0795 | 0.8975 | 1.0116 |
| FA (19:1) | 0.8277 | 1.3253 | 0.8831 |
| FA (20:0) | 1.1937 | 0.5277 | 1.2261 |
| FA (20:1) | 1.1114 | 0.8564 | 1.0162 |
| FA (20:2) | 0.7861 | 1.4228 | 0.8381 |
| FA (20:3) | 0.9122 | 0.9663 | 1.1177 |
| FA (20:4) | 1.0025 | 0.8255 | 1.1526 |
| FA (22:1) | 1.0478 | 0.8837 | 1.0556 |
| [FA (22:4)] 7Z_10Z_13Z_16Z-docosatetraenoic acid | 0.9755 | 0.9472 | 1.0715 |
| FA (22:5) | 0.7528 | 1.2407 | 1.0332 |
| FA (23:1) | 0.8281 | 1.3249 | 0.8831 |
| [FA (24:0)] 15Z-tetracosenoic acid | 0.9362 | 1.1160 | 0.9606 |
| [FA (26:0)] hexacosanoic acid | 1.0846 | 0.7431 | 1.1438 |
| [FA (34:2)] 1-octadecyl-11E-hexadecenoate | 0.4433 | 1.9569 | 0.7061 |
| FA dimethyl(20:3) | 1.1476 | 0.4130 | 1.3741 |
| FA hydroxy(12:0) dodecanoic acid | 1.2124 | 0.4844 | 1.2460 |
| FA hydroxy(18:0) | 1.1662 | 0.3152 | 1.4425 |
| FA hydroxy(18:1) | 0.9147 | 1.4893 | 0.6504 |
| FA hydroxy(18:1)] | 0.8992 | 1.0905 | 1.0204 |
| FA hydroxy (18:2) | 0.4042 | 2.4053 | 0.3466 |
| FA hydroxy(18:2) | 1.0052 | 0.8714 | 1.1091 |
| FA hydroxy(20:1) | 1.0800 | 0.7636 | 1.1301 |
| FA hydroxy(20:3) | 1.8600 | 0.5643 | 0.5273 |
| FA hydroxy(20:4) | 2.3805 | 0.2784 | 0.2610 |
| FA hydroxy(22:0) | 1.1449 | 0.6467 | 1.1692 |
| FA methyl(14:0) | 0.7988 | 1.3834 | 0.8604 |
| FA methyl(16:1) | 0.8375 | 1.4133 | 0.7951 |
| FA methyl(18:0) | 0.6098 | 1.6891 | 0.7776 |
| [FA oxo(14:0)] 3-oxo-tetradecanoic acid | 1.2001 | 0.5643 | 1.1872 |
| FA oxo(14:2) cyclopentanebutanoic acid | 0.6891 | 1.7834 | 0.6146 |
| [FA oxo(16:2)] cyclopentanehexanoic acid | 0.5711 | 1.9370 | 0.5960 |
| FA oxo(18:0) | 1.1794 | 0.7493 | 1.0434 |
| GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) | 1.1859 | 0.5458 | 1.2177 |
| GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) | 0.9139 | 1.3796 | 0.7487 |
| GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d34:1)) | 1.0922 | 0.7154 | 1.1607 |
| Ganglioside GD3 (d18:0/14:0) | 1.1078 | 0.7506 | 1.1139 |
| Ganglioside GM3 (d18:0/16:0) | 1.1804 | 0.7676 | 1.0262 |
| ginsenoside Rh2 | 0.4283 | 2.2564 | 0.4549 |
| [GL (18:0/20:4)] 1-(9Z-octadecenoyl)-2-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-3-O-alpha-D-glucuronyl-sn-glycerol | 1.0256 | 0.3308 | 1.0700 |
| Hexadecanoic acid | 1.1101 | 0.7434 | 1.1180 |
| Homophytanicacid | 0.8698 | 1.0171 | 1.1150 |
| indole-3-acetyl-methionine | 1.0775 | 0.7933 | 1.1063 |
| LysoPE(20:1) | 0.9832 | 1.1002 | 0.9277 |
| LysoPE(20:5) | 1.2207 | 0.3465 | 1.3602 |
| LysoPE(22:5) | 0.9540 | 0.9035 | 1.1317 |
| Melampodinin | 1.0814 | 0.8492 | 1.0526 |
| MG(0:0/16:0/0:0) | 1.0187 | 0.9431 | 1.0319 |
| MG(0:0/22:4(7Z_10Z_13Z_16Z)/0:0) | NA | 1.0000 | NA |
| N-(2-hydroxypentacosanoyl)-phytosphingosine | 1.1874 | 0.4472 | 1.3040 |
| N-(2-hydroxy-tetracosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine | 0.6160 | 1.8918 | 0.5913 |
| N-(2-hydroxytricosanoyl)-phytosphingosine | 1.2297 | 0.3695 | 1.3308 |
| N-(octadecanoyl)-1-beta-glucosyl-4E_6E-pentadecasphingadienine | 1.3354 | 0.3064 | 1.2812 |
| N-(octadecanoyl)-1-beta-glucosyl-pentadecasphing-4-enine | 1.2859 | 0.1895 | 1.3444 |
| Octadecanoic acid | 1.2088 | 0.4629 | 1.2686 |
| PA(18:1(9Z)/0:0) | 0.9811 | 0.3386 | 1.6068 |
| PA(18:2(9Z_12Z)/0:0) | 0.7167 | 0.8005 | 1.4607 |
| [PA(20:4(5Z_8Z_11Z_14Z)/0:0)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phosphate | 0.8781 | 0.4220 | 1.6357 |
| Patellamide A | 0.8004 | 1.4898 | 0.7582 |
| PC(21:0(CHO)) | 0.9461 | 1.1198 | 0.9475 |
| PC(21:0(COOH)) | 0.8571 | 1.3264 | 0.8527 |
| [PE(16:1)] 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine | 0.7482 | 1.6518 | 0.6724 |
| PE(16:2) | 0.8096 | 1.6489 | 0.6136 |
| PE(17:0) | 0.7845 | 1.5109 | 0.7613 |
| PE(30:0) | 1.0919 | NA | 0.9081 |
| PE(30:1) | 1.0883 | NA | 0.9117 |
| PE(32:1) | 1.3049 | 0.5743 | 1.0736 |
| PE(34:0) | 1.2901 | 0.6484 | 1.0224 |
| PE(36:0) | 1.0928 | 0.1108 | 1.1049 |
| PE(36:5) | 1.2282 | 0.7135 | 1.0264 |
| PE(38:1) | 1.2927 | 0.6171 | 1.0477 |
| PE(38:2) | 1.1077 | 0.9431 | 0.9429 |
| PE(40:4) | 1.1673 | 0.4741 | 1.3001 |
| PE(40:5) | 1.1313 | 0.5279 | 1.2884 |
| PE(40:8) | 1.2458 | 0.6562 | 1.0597 |
| [PE(O-18:2)] 1-octadecyl-sn-glycero-3-phosphoethanolamine | 0.9563 | 1.3400 | 0.7415 |
| PE(O-20:0/0:0) | 0.9449 | 1.3346 | 0.7576 |
| PE(O-42:4) | 1.0963 | 0.8575 | 1.0304 |
| PE(P-20:0) | 0.9472 | 1.1782 | 0.8944 |
| PE(P-20:0/22:4(7Z_10Z_13Z_16Z)) | 1.1666 | 0.8699 | 0.9490 |
| PE(P-42:6) | 1.0715 | 0.7139 | 1.1828 |
| [PG (16:0)] 1-hexadecanoyl-sn-glycero-3-phospho-(1^-sn-glycerol) | 1.1223 | 0.9109 | 0.9570 |
| PG(17:0/14:1) | 1.2061 | 0.0214 | 1.1201 |
| [PG (18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1^-sn-glycerol) | 1.1470 | 0.9705 | 0.8792 |
| PG(32:0) | 1.5530 | 0.2227 | 1.1379 |
| PG(34:0) | 1.2165 | 0.8220 | 0.9418 |
| PG(34:1) | 1.3691 | 0.2531 | 1.2948 |
| PG(36:1) | 1.4314 | 0.2994 | 1.1914 |
| PG(36:2) | 1.1659 | 0.6135 | 1.1777 |
| PG(36:3) | 1.1567 | 0.6226 | 1.1788 |
| PG(36:4) | 0.6959 | 1.6339 | 0.7407 |
| [PI(16:0)] 1-hexadecanoyl-sn-glycero-3-phospho-(1^-myo-inositol) | 0.7872 | 1.6664 | 0.6204 |
| [PI(18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1^-myo-inositol) | 0.9347 | 1.3563 | 0.7486 |
| PI(18:2) | 0.5540 | 2.0598 | 0.5039 |
| [PI(20:4)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1^-myo-inositol) | 0.9314 | 1.1840 | 0.9050 |
| PI(32:1) | 1.2337 | 0.4540 | 1.2516 |
| PI(34:0) | 1.1057 | 0.6998 | 1.1612 |
| PI(34:1) | 1.3497 | 0.2480 | 1.3187 |
| PI(34:2) | 1.7423 | 0.5124 | 0.6911 |
| PI(34:3) | 1.5393 | 0.5176 | 0.8895 |
| PI(35:2) | 0.5797 | 1.8588 | 0.6569 |
| [PI(36:0) | 1.4400 | 0.4345 | 1.0626 |
| PI(36:1) | 1.3852 | 0.2958 | 1.2408 |
| PI(36:2) | 1.0089 | 0.8719 | 1.1050 |
| PI(36:3) | 0.9526 | 0.9228 | 1.1160 |
| PI(36:4) | 1.0470 | 0.7739 | 1.1540 |
| PI(37:4) | 0.7943 | 1.3266 | 0.9153 |
| PI(38:3) | 1.1141 | 0.5923 | 1.2483 |
| PI(38:4) | 1.1178 | 0.5511 | 1.2812 |
| PI(38:5) | 1.0171 | 0.6582 | 1.2867 |
| PI(40:4) | 1.1024 | 0.6203 | 1.2351 |
| PI(40:7) | 1.1419 | 0.3649 | 1.4227 |
| PI(P-33:1) | 1.0046 | 0.9081 | 1.0771 |
| Proscillaridin A | 0.8741 | NA | 1.0839 |
| PS(18:0) | 1.0902 | 1.0548 | 0.8610 |
| [PS(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine | 1.2433 | 0.8031 | 0.9317 |
| PS(19:0/0:0) | 0.9909 | 0.9817 | 1.0254 |
| PS(20:0/0:0) | 0.9023 | 1.2156 | 0.9061 |
| [PS(20:4)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phosphoserine | 1.1992 | 0.7219 | 1.0479 |
| PS(21:0/0:0) | 1.2290 | 0.5221 | 1.1959 |
| PS(22:0/0:0) | 0.7267 | 1.6010 | 0.7391 |
| PS(33:0) | 1.4605 | 0.0723 | 1.3642 |
| PS(35:0) | 1.3242 | 0.3667 | 1.2387 |
| PS(35:1) | 1.3453 | 0.4839 | 1.1134 |
| PS(36:0) | 1.1641 | 0.7082 | 1.0953 |
| PS(36:1) | 0.8570 | 1.3345 | 0.8456 |
| PS(36:3) | 1.6760 | 0.6930 | 0.6038 |
| PS(36:4) | 1.6098 | 0.5716 | 0.7235 |
| PS(37:0) | 1.2861 | 0.3917 | 1.2546 |
| PS(37:1) | 1.0461 | 0.8828 | 1.0581 |
| PS(37:2) | 1.2215 | 0.4964 | 1.2261 |
| PS(37:3) | 1.2691 | 0.3353 | 1.3217 |
| PS(38:0) | 1.1739 | 0.6001 | 1.1815 |
| PS(38:1) | 0.6495 | 1.6975 | 0.7306 |
| PS(38:2) | 0.8806 | 1.2221 | 0.9220 |
| PS(38:3) | 1.1003 | 0.7398 | 1.1310 |
| PS(38:5) | 3.6049 | 0.2334 | 0.1766 |
| PS(38:6) | 1.4471 | 0.5222 | 0.9776 |
| PS(39:0) | 1.3062 | 0.2213 | 1.3860 |
| PS(39:1) | 1.0774 | 0.7495 | 1.1453 |
| PS(39:2) | 1.1131 | 0.6651 | 1.1846 |
| PS(39:3) | 1.1638 | 0.5470 | 1.2389 |
| PS(39:4) | 1.2884 | 0.3978 | 1.2469 |
| PS(39:5) | 1.2788 | 0.2806 | 1.2807 |
| PS(40:0) | 1.0110 | 0.5454 | 1.3931 |
| PS(40:1) | 0.3027 | 2.4840 | 0.3782 |
| PS(40:2) | 0.6939 | 1.5769 | 0.7933 |
| PS(40:3) | 0.8814 | 1.1039 | 1.0262 |
| PS(40:5) | 1.1828 | 0.7878 | 1.0058 |
| PS(41:0) | 1.3025 | 0.2413 | 1.3719 |
| PS(41:1) | 1.1202 | 0.6201 | 1.2175 |
| PS(41:2) | 1.1431 | 0.4398 | 1.3548 |
| PS(41:3) | 1.1489 | 0.4374 | 1.3511 |
| PS(41:4) | 1.1260 | 0.5681 | 1.2579 |
| PS(41:6) | 1.1644 | 0.3603 | 1.4042 |
| PS(42:2) | 0.7506 | 1.2832 | 0.9977 |
| PS(42:3) | 0.6282 | 1.6016 | 0.8370 |
| PS(43:0) | 1.1726 | 0.2054 | 1.2688 |
| PS(43:2) | 1.1010 | 0.6436 | 1.2158 |
| PS(43:21) | 0.9756 | 0.9453 | 1.0730 |
| PS(43:6) | 1.1101 | 0.5295 | 1.3081 |
| PS(44:5) | 0.6730 | 1.5823 | 0.8094 |
| PS(O-16:0/21:0) | 1.0248 | 0.9867 | 0.9870 |
| PS(O-37:1) | 0.5396 | 2.0288 | 0.5459 |
| PS(O-39:0) | 1.0981 | 0.5631 | 1.2903 |
| PS(O-41:0) | 1.3092 | 0.4177 | 1.2084 |
| PS(P-18:0/22:6(4Z_7Z_10Z_13Z_16Z_19Z)) | 1.0572 | 0.8544 | 1.0722 |
| PS(P-20:0/21:0) | 1.0641 | 0.7035 | 1.1995 |
| PS(P-39:0) | 0.7736 | 1.5308 | 0.7546 |
| PS(P-39:1) | 0.6489 | 1.8654 | 0.5819 |
| Retinyl ester | 0.9794 | 1.0147 | 1.0076 |
| Sapelin A | 0.3988 | 2.2521 | 0.4882 |
| soyasapogenol B-22-O-beta-glucoside | 0.2305 | 2.7179 | 0.2424 |
| [SP amino_trihydroxy_hydroxy_methyl_oxo(20:0)] 2S-amino-3R_4R_5S-trihydroxy-2-(hydroxymethyl)-14-oxo-eicos-6E-enoic acid | 0.8605 | 1.4517 | 0.7380 |
| [SP] Sphing-4-enine-1-phosphate | 1.1292 | 0.8184 | 1.0322 |
| [ST hydroxy(2:0)] (5Z_7E)-(1R_2R_3R)-2-(5-hydroxypentoxy)-9_10-seco-5_7_10(19)-cholestatriene-1_3-diol | 0.4498 | 2.1468 | 0.5308 |
| [ST hydroxy(4:0)] 1beta_3alpha_7alpha_12alpha-Tetrahydroxy-5beta-cholan-24-oic Acid | 1.1298 | 0.7474 | 1.0947 |
| [ST methy] 24-methylene-cholest-5-en-3beta-ol-3-sulfate | 0.5010 | 1.9700 | 0.6368 |
| Stylisterol B | 0.5086 | 1.9946 | 0.6073 |
| Teasterone | NA | 1.0000 | NA |
| Tetracosanoic acid | 1.1528 | 0.7646 | 1.0564 |
| TG(12:0/12:0/12:0) | 0.8623 | 1.5754 | 0.6262 |
| Thiocoraline | 1.1161 | 0.9107 | 0.9633 |
| Tritriacontane-16_18-dione | 0.6045 | 1.5858 | 0.7869 |
Factors:
| F1 | Treatment:Celecoxib_HFD |
| F2 | Treatment:CFD |
| F3 | Treatment:HFD |
